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ABSTRACT
Contrary to several earlier reports, we find that
cross-recombination between wild-type and the
mutant loxP511 sites is ,0.5% of that between two
wild-type sites if Cre protein is expressed by phage
P1 during an infection. The finding enabled us to
develop a procedure to truncate DNA progressively
from both ends of large genomic inserts flanked
by these two loxP sites in pBACe3.6 and related
vectors with transposons carrying either a wild-type
or a loxP511 sequence. Newly constructed loxP511
transposonscontainedeitherakanamycinresistance
gene or no marker. Insert DNA ends in deletions were
sequenced with primers unique to each transposon-
end remaining after the respective recombination.
End-sequencing 223 deletions confirmed that the
low level of cross-recombination, observed between
those sites during the P1 transductions, does not
complicate the procedure: truncations from the
unintended end of genomic inserts did not occur.
Multiple BACs pooled together could also be pro-
cessed in a single tube to make end-deletions.
This deletion technology, utilizing the very minimal
cross-recombination between the mutant and wild-
type loxP sites of most BAC clones in the public
domain and a heterologous one inserted as a trans-
poson, should facilitate functionally mapping long-
range gene regulatory sequences and help to isolate
genes with defined functional boundaries in numer-
ous projects including those of therapeutic interest.
INTRODUCTION
A comparison of genomic sequences indicates much of the
DNA that is highly conserved between human and mouse do
not actually code for proteins (1), but is thought to be involved
in regulating gene expression (2,3). Part of this conserved non-
coding DNA comprises Cis-acting sequences, sometimes loc-
ated far away from the coding region of a gene, regulating
transcription (2–5). Identifying these functionally presents a
majorchallengebecausetraditionalapproacheshaveaddressed
only short range interactions between DNA sequence modules
in small plasmids.
Localizing regulatory sequences distal to a gene function-
ally requires that the gene and its regulators be housed in large
insert clones such as BACs or PACs (6–8). Libraries of clones
with large inserts and high coverage of human, mouse and rat
DNA exist (9–11), and the availability of a set of BAC clones
spanning the entire human genome has set the stage for serious
functional mapping projects (12). Procedures capable of trun-
cating large genomic inserts in clones from these libraries
should facilitate such effort (13–19).
Methods that progressively delete DNA from one end of
genomic inserts in BACs and PACs have been described, and
used to localize genetic markers on a physical map of the
chromosome (20,21). Cre recombination of a randomly trans-
posed loxP site to insert DNA with one endogenous to the
clone generates a deletion series. The resulting truncations are
recovered by packaging in a phage P1, with the size of clones
limited to 110 kb. Despite this size limitation, the ease of
scanning 100 kb of conserved non-coding DNA for gene regu-
latory sequences quickly is a distinct advantage, and the pro-
cedure was used recently to functionally identify three new
enhancer sequences 27 kb upstream of the Nkx2-5 gene in
transgenic mice (3).
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doi:10.1093/nar/gni119Because regulatory elements can sometimes be within
introns or located downstream of a gene, it would be desirable
to be able to truncate BAC inserts from both ends. Fortunately
cloning vehicles, such as the pBACe3.6 and pTARBAC1 or
pTARBAC2 vectors, used for the newer resource libraries
contain the insert DNA ﬂanked by two different loxP sites
(22). An arrangement such as this might have been considered
ideal for deleting DNA from both ends with transposons
carrying the different loxP sites had results from several
subsequent studies not discouraged developing such strat-
egies: cross-recombination between wild-type and the mutant
loxP511 site that ﬂanked DNA inserts in these clones, have
been reported to range from 5 to 100% in a variety of settings
(19,23–26).
A recent study using a pair of different loxP site mutants
suggests the earlier ﬁndings might have been inﬂuenced
by excessive and/or sustained levels of Cre protein from
constitutive expression, during recombination (27). Cross-
recombinationbetweenwild-type and loxP511sites was there-
fore, reinvestigated using transient expression of Cre protein
which occurs during phage P1 transduction. We now report
that the leakage in recombination between these two sites was
found to be not more than 0.5% of that between two wild-type
sites. The results enabled us to progressively delete both
ends of genomic inserts in pBACe3.6 and related vectors
using transposons that carry either a wild-type or a mutant
loxP511 site.
MATERIALS AND METHODS
The oligodeoxyribonucleotides, d (GGCCGCTAATAACTT-
CGTATAGTATACATTATACGAAGTTATTGTTTAAACC)
and d (GGCCGGTTTAAACAATAACTTCGTATAATGTA-
TACTATACGAAGTTATTAGC), were annealed by heating
equimolar quantities in 10 mM Tris–HCl, pH 8.0, buffer
containing 1 mM EDTA and 10 mM NaCl to 70C and
slow cooling to room temperature. The duplex oligo contains
the mutant loxP511 sequence along with a PmeI site, and was
ligated to plasmid DNA linearized with NotI enzyme.
Construction of Tn10 minitransposons with mutant
loxP511 sites
The transposon plasmid pTnloxP*-1 (27), was the starting
point for all mutant loxP511 site-containing plasmids. The
gene for chloramphenicol resistance located near one of
the 70 bp inverted repeat ends was removed by digesting the
pTnloxP*-1 DNA to completion with PvuII, gel purifying the
largest fragment, and performing a partial digest with ScaI.
The largest fragment was again gel puriﬁed, and the two blunt
ends created by the PvuII and ScaI enzymes ligated with
high concentration T4 DNA ligase. Transformed colonies
were selected on LB agar plates with ampicillin. The gene
for ampicillin resistance is located outside the 70 bp inverted
repeat ends of the transposon.
Next the sequences for tetracycline resistance gene and the
mutant loxP*-1 site were removed by NotI digestion, and it
was ligated with a duplex oligonucleotide with NotI compat-
ible ends that contained the mutant loxP511 sequence and a
PmeI restriction site (shown above). Plasmids acquiring the
loxP511 oligonucleotide were screened for by digesting
clone DNA with PmeI enzyme. Both orientations of the
loxP511 site-inserted transposon were isolated. They were
named pTnLoxP511(A)markerless 1 and pTnLoxP511(B)-
markerless 1. They are designated markerless because they
do not contain any antibiotic resistance markers within the
70 bp inverted repeat ends of the transposon to select for
transpositions of the loxP511 site into target DNA [see
discussion (28)].
An additional oligonucleotide duplex for anchoring
a sequencing primer (Seq 25) was inserted into the
unique AscI site of pTnLoxP511(B)markerless 1 to generate
pTnLoxP511(B)markerless 2. The plasmid was linearized
with AscI and the duplex obtained by hybridizing the follow-
ing oligonucleotides M13C and M13D was ligated as
described above.
M13C: d (CGCGCCTAGTAAAACGACGGCCAGTAG-
TCGTGACTGGGAAAACCTGTTTAAACC); M13D: d
(CGCGGGTTTAAACAGGTTTTCCCAGTCACGACTACT-
GGCCGTCGTTTTACTAGG).
A RSV neomycin resistance gene cassette, coding for kana-
mycin resistance in bacteria, was excised from pTnBAC/loxP
(14) with AscI, and inserted into the AscI site of pTnLox-
P511(B)markerless 1 (Figure 1). The resulting transposon
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Figure 1. New transposonplasmids containing wild-type and loxP511 sites. A
schematic representation of transposonplasmids used for deletingboth ends of
insert DNA cloned in the pBACe3.6 and related vectors pTARBAC1 and
pTARBAC2. The transposon plasmid pTnLoxP511(B)markerless 1, shown
in the top panel, has no antibiotic resistance marker within the transposing part
marked by the small rectangular boxes colored pink or green. Bottom panel
shows a kanamycin resistance gene-containing variant, pTnLoxP511(B)RSV-
neo 2. The middle panel shows a wild-type loxP transposon plasmid with
kanamycin resistance gene. Wild-type loxP site is shown with the thick con-
tinuous arrow, while the mutant loxP511 sites are indicated by bold broken
arrows.ThepinkendRremainsindeletionclonesgeneratedwiththewild-type
loxP transposons, while the green end L is left behind in deletions with the
loxP511 transposons.
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pTnLoxP511(B)RSVneo 2 to distinguish the two orientations
of the RSVneo cassette. Only pTnLoxP511(B)RSVneo 2 is
discussed here.
Construction of a Tn10 minitransposon with
wild-type loxP sites
The kanamycin resistance gene-containing wild-type loxP
transposon plasmid, pTn(RSVneo 2)/loxP, was constructed
by introducing a RSV neomycin gene cassette into the previ-
ously described pTnMarkerless2 transposon plasmid (28). It
differs from pTnBAC/loxP (14) in that all sequences related to
the chloramphenicol resistance gene were removed from the
latter, in order to reduce recombination between the chloram-
phenicol resistance gene in BACs and those sequences in the
pTnBAC/loxP plasmid (14) [see discussion (28)]. The RSV
neomycin gene cassette was excised from pTnBAC/loxP with
AscI, the DNA fragment puriﬁed from an agarose gel, and
ligated to pTnMarkerless2 linearized also with AscI. Plasmids
containingbothorientationsofthe RSVneogenecassettewere
isolated, pTn(RSVneo 1)/loxP and pTn(RSVneo 2)/loxP, and
only the latter orientation used here and shown in Figure 1.
Generating deletions from the loxP511 end of
inserts in pBACe3.6 vector-derived clones
The following 10 clones from the human and mouse
BAC libraries were obtained from BACPAC resources,
CHORI (Oakland, CA): RP11-219A15, RP11-158M20,
RP11-434D2, RP23-209O22, RP23-92L23, RP23-366M16,
RP23-101N20, RP23-124B2, RP23-444K15, RP23-130D16.
The genomic inserts in these clones are ﬂanked by a wild-
type and a mutant loxP511 site in the BAC vector pBACe3.6
(9–11,22).
Nested deletions using pTnLoxP511(B)markerless 1,
pTnLoxP511(B)markerless 2 and pTnLoxP511(B)RSVneo
2 from the loxP511 end were generated in each of the
above clones as previously described (28,29).
Processing multiple BAC clones to make end-deletions
BACs were also pooled together and processed together in
a single tube to make end-deletions. Each BAC clone was
transformed separately with the transposon plasmid, and the
transformed colonies grown to saturation before pooling.
End-sequencing of BAC deletion clones
Typically, miniprep DNA was isolated from 60 clones picked
randomly from the several hundred member BAC deletion
library. Deletion clones were passed through an ampicillin
sensitivity screen (20) if the transposon plasmid was recovered
in more than 20% of the deletions. Approximately half the
clones from the ﬁrst round deletion series analyzed on FIGE
were of unique size. Deletions arising from intra-insert
recombinations independent of loxP-Cre, seen only when
using markerless transposons of either type, were weeded
out after FIGE analysis (lane 1 of Figure 2 shows an e.g.).
These are identiﬁed by their BAC vector DNA fragment
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Figure 2. FIGE analysis of NotI digested DNA isolated from progressive truncations made from one or both ends of insert DNA. Left panel: DNA isolated from
deletionclonesgeneratedwitheitherpTnLoxP511(B)markerless1(lanes3–15)orpTnLoxP511(B)RSVneo2(lanes19–30)inBACcloneRP23-444K15andRP11-
219A15,respectively,wereanalyzedbyFIGE.Lane17containstheDNAfromstartingBACcloneRP23-444K15,whilelanes2,18and41contain5kbDNAladders.
Right panel: Second round deletions made with pTn(RSVneo 2)/loxP from the wild-type loxP end of insert DNA from the deletion clone shown in lanes 3 and 31.
Lanes32–40showdeletions,while42–48showinversions.Deletions withpTnLoxP511(B)RSVneo 2(lanes19–30)producea 10.5kb BACvectorDNA fragment,
while those with pTnLoxP511(B)markerless 1 (lanes 3–15) produce no BAC vector band because one of the NotI sites is lost as a result of the deletion (Figure 3).
Intra-insert deletions independent of LoxP-Cre recombination produce the same sized BAC vector band as starting BAC (lane 1).
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each deleted series was sequenced directly using a transposon-
end primer (20) and Big dye terminator chemistry on an ABI-
3100 AVANT genetic analyzer. Primer extended products
were puriﬁed using Magnesil (Promega Corporation) accord-
ing to procedures supplied by the manufacturer and described
in (27,28). Primers for sequencing newly created ends of dele-
tions from the loxP511 side of insert DNA, after trimming the
wild-type end, have been developed. These are listed below:
Sequencing primers
Seq 8: d (GCAGTGTGACCGTGTGCTTCTCAAATGC);
Seq 21: d (GATCGGCGCGCCATGATC); Seq 25: d
(GCCAGTAGTCGTGACTG); Neo 8: d (GTTTTCCCTTG-
TCCAGATAGC); Neo 11: d (CTGAGTGCTTGCGGCA-
GCG); Neo 12: d (GAATCGTTTTCCGGGACG); Neo 16:
d (GATCTCATGCTGGAGTTCTTCGCC).
RESULTS
Truncating DNA inserts from both ends using loxP transpo-
sons critically depends on the degree of leakage in recomb-
ination between the two loxP sites ﬂanking the insert. Because
varying degrees of recombination cross-reactivity between
these sites was observed in previous studies (19,23–26), it
was important to reinvestigate this under the P1 transduction
conditionsthatareactuallyusedinourdeletionprocedure(27).
Estimating recombination cross-reactivity between
wild-type and mutant loxP511 sites using
phage P1 transduction
Several mutant loxP sites have been tested both for their
recombination efﬁciency and exclusivity under different
Cre protein-exposure conditions (23–27). Phage P1 expresses
Cre early during an infection and efﬁciently transduces a wild-
type loxP plasmid with high ﬁdelity (30–32). The ability of the
wild-type loxP site in phage P1 to transduce the mutant
loxP511 plasmid was used as an indicator of recombination
cross-reactivity between these sites (27). Results in Table 1
indicated that although P1 was able to efﬁciently transduce the
plasmid with a wild-type site, it could recover the mutant
loxP511 plasmid only very inefﬁciently (compare #17 with
#21). Unlike the results with two other mutant loxP sites
described earlier (27), inhibition of transduction of the
loxP511mutant was incomplete. Comparing parallel transduc-
tions we ﬁnd that the loxP511 plasmid is transduced 0.1–0.5%
as efﬁciently as the wild-type. This level of recombination
cross-reactivity is signiﬁcantly less than that which was repor-
ted earlier in several in vivo and in vitro analyses (19,23–26).
The exclusivity between the two sites appears high, although
not absolute as reported originally (33). Consistent with pre-
vious ﬁndings (27), phage P1 was able to efﬁciently transduce
the loxP511 plasmid if another carrying both a wild-type and
the loxP511 site exists in the cell (rows 5, 6, Table 1). Phage
P1 transduced the loxP511 plasmid in the presence of BAC
deletions, #39 and #45, generated from BAC RP23-444K15 by
truncating from the wild-type loxP end with a markerless
wild-type loxP transposon (28).
Generating deletions from the loxP511 end of insert
DNA in pBACe3.6
Because the 511 and wild-type loxP sequences cross-
recombine only slightly, insert DNA ﬂanked by these can
be deleted from both ends using transposons carrying those
sites. Verifying authenticity of the newly created ends after
each round of deletion should compensate for the minor leaki-
ness. Transposons were constructed with the two types of loxP
sites such that a different end of the Tn10 was left behind after
deletion formation at each end of insert DNA. Unique primers
were designed into each transposon-end remaining after the
recombination.
Two classes of transposons were constructed carrying the
loxP511 site: (i) markerless and (ii) with kanamycin resistance
gene as marker. Only transposons of the ‘B’ series of both
classes, with the loxP511 oriented as shown in Figure 1, were
used in this study. The ‘A’ series of both classes had the
loxP511 site in the opposite orientation. As noted earlier
(28), transposition of a markerless loxP transposon is selected
through P1-headful packaging and not by the transfer of an
antibiotic resistance gene into the target DNA. This necessit-
ates the starting BAC to be larger than P1-headful size.
Depending on which end of the genomic insert is deleted
ﬁrst, the markerless transposon could carry a wild-type or a
mutant loxP511 site. Markerless transposons with wild-type
loxP sites have been previously described (28).
The transposon plasmid pTnLoxP511(B)markerless 1 was
transformed into each of the 10 BACs listed in Materials and
Methods. Transformed colonies were selected on LB agar
plates containing chloramphenicol plus ampicillin. Colonies
Table 1. P1 transduction of plasmids carrying wild type and/or loxP511 sites.
Clone Size (kb) Marker LoxP site After transduction with phage P1
kan cam
#17 12 camR Wild-type loxP only N/A +++++
a
#21 8 kanR loxP511 only +
b N/A
#39 40 camR Wild-type plus loxP511 N/A +++++
a
#45 60 camR Wild-type plus loxP511 N/A +++++
a
Transformed clones
#39/21 +++++
a +++++
a
#45/21 +++++
a +++++
a
Wt loxP ATAACTTCGTATA GCATACAT TATACGAAGTTAT
loxP511 ATAACTTCGTATA GTATACAT TATACGAAGTTAT
b+, 5 colonies/plate.
a+++++, 1000 colonies/plate.
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deletions as described earlier for wild-type loxP transposon-
transformed BACs (28,34). BAC deletions were selected on
plates that contained chloramphenicol only. Miniprep DNA
isolated from deletion clones were digested with NotI enzyme
before analysis by FIGE (29). Lanes 3–15 of Figure 2 shows
DNA isolated from clones deleted from the loxP511 end of
insert in BAC RP23-444K15. Lane 1 displays an intra-insert
deletion independent of loxP-Cre (28), with the vector DNA
fragment size identical (8.8 kb) to starting BAC (lane 17).
Deletions from the loxP511 end were also made with
pTnLoxP511(B)RSVneo 2 (Figure 1) in a subset of the
BAC clones. Lanes 19–30 Figure 2, shows NotI digested
DNA from a set of these deletions with the BAC vector frag-
ment now at 10.5 kb.
Specificity of loxP-Cre recombinations during deletion
formation: using size of pBACe3.6 vector DNA
fragment with NotI as a diagnostic
The two Not I sites in pBACe3.6 vector are located asymmet-
rically with respect to the loxP sites: the NotI sites at positions
2,849 and 11583 are 1.978 and 0.142 kb in front of the wild-
type and mutant loxP511 sites, respectively (35) (Figure 3).
Transposons pTnLoxP511(B)RSVneo 2 and pTn(RSVneo 2)/
loxP would substitute the BAC vector NotI site with one from
the transposon after recombining the respective loxP sites
(Figures 1 and 3). Because the NotI sites in both transposons
are 1.7 kb away from their respective loxP sites, they would
yield BAC vector DNA NotI-fragments of different size in
clones deleted from the wild-type or the mutant loxP511 ends
of insert: recombinations with either the mutant 511 or wild-
type loxP sites in the BAC would produce a 10.5 or 8.4 kb
vector DNA fragment with NotI, respectively, (lanes 19–30
and 16–30 in Figures 2 and 4, respectively). Note that frag-
ments of 10.5 and 8.4 kb did not appear together during a
deletion experiment with either of these transposons, demon-
strating the exclusivity of the recombination reactions. It cor-
roborates the selectivity observed during the P1 transductions
described above. Deletion-end-sequencing with Tn-based
primers also support the conclusion.
Deletions from the wild-type loxP end of insert DNA with
pTnMarkerless2, described earlier (28), yield the expected
vector DNA NotI-fragment of 6.8 kb (lanes 1–13, Figure 4).
Intra-insert deletions independent of LoxP-Cre recombination
are isolated only when using markerless transposons (28),
because the probability of isolating one in conjunction with
a transposon insertion is low, and can be easily identiﬁed by
their BAC vector DNA fragment with NotI: it is the same size
as the starting BAC, as shown in lane 1 of Figure 2. Note
that markerless transposons cannot be used for second round
deletions because the starting clone would be less than P1-
headful size (28).
A new wild-type loxP transposon pTn(RSVneo 2)/loxP was
used to make deletions from the wild-type end of insert DNA,
producing the expected 8.4 kb BAC vector DNA fragment
with NotI (lanes 16–30, Figure 4).
Truncating insert DNA from both ends sequentially
in the same BAC
Trimming either end of insert DNA in pBACe3.6 derived
clones was readily achieved using transposons speciﬁc for
the respective ends.Both ends in the same clonecan be deleted
similarly except that the second round of deletions must neces-
sarily be performed with a resistance gene marker-containing
Figure 3. Schematicrepresentationofdeletionsmadesequentiallyfromthe(i)mutantloxP511endofgenomicDNAinsertgeneratedwithpTnLoxP511(B)marker-
less 1 (top panel) and (ii) wild-type loxP end with pTn(RSVneo 2)/loxP (bottom panel). The transposon is shown as the triangle with the locations of NotI sites
indicated.NotethatCremediateddeletionsgeneratedwiththeloxP511siteswouldsubstituteaNotIwithaPmeIsite(toppanel).Deletionsusingthewild-typeloxP
sites would retain the NotI site as shown in the bottom panel.
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wild-type or the loxP511, will be truncated ﬁrst dictates the
choice of markerless transposon: pTnMarkerless2 [with wild-
type loxP (28)] or pTnLoxP511(B)markerless 1 (Figure 1).
A second round of truncations with pTn(RSVneo 2)/loxP
was made with the largest clone in the deletion series obtained
with pTnLoxP511(B)markerless 1 (shown in lanes 3 and 31 of
Figure 2). NotI digested DNA isolated from clones obtained in
the second round of deletions is shown in lanes 32–40,
Figure 2. Because the starting clone here was <110 kb, both
deletions and inversions were isolated in about equal numbers
(14,29). Inversions are shown in lanes 42–48 (Figure 2).
Similar truncations from both ends were also made by delet-
ing ﬁrst from the wild-type loxP end of inserts with pTnMark-
erless2, and then using pTnLoxP511(B)RSVneo 2 to trim the
other end of a clone isolated in the ﬁrst round deletions (data
not shown).
Processing a mixture of BAC clones transformed with
transposon plasmid to increase throughput of
making end-deletions
Multiple BACs can be processed together as a mixture in a
single tube to make end-deletions. Because clones tend to
have different growth characteristics, this is best achieved
by transforming each clone separately with the desired trans-
poson plasmid and growing them to saturation before pooling.
As many as 32 BACs were transformed in parallel. Aliquots
from nine such tansformed BAC cultures were pooled, and
processed for deletions exactly as described earlier (29). For
simplicity of sequencing downstream, BACs in a pool were
transformed with the same Tn-plasmid. Each deletion was seq-
uenced with primers speciﬁc to both ends of the insert DNA
remaining after the deletion i.e. one from the transposon, the
otherspeciﬁcto the oppositeunaltered end ofinsertDNA (SP6
or T7). The latter sequence helped identify the parent from
which the deletion was obtained. Analysis of the results indic-
atesalthougheachofthenineBACsisrepresentedindeletions,
the distribution is quite skewed: deletions from clone RP23-
444K15 dominate 4-fold over those from RP11-219A15,
RP23-209O22 or RP23-92L23, although all four were equally
efﬁcient in producing deletions when processed individually.
Sequencing ends of deletions with primers from the
wild-type or loxP511 transposons
Transposon-ends marked R (pink) and L (green) shown in
Figures 1, 3 and 5 remain after deleting from the wild-type
or loxP511 end of insert DNA, respectively. Note that
the opposite orientation of the loxP511 site in transposons
of the ‘A’ series would have left behind the R (pink) end
in a deletion, and this would have interfered during end-
sequencing of clones after a second round of deletions with
the wild-type loxP transposon. Because both ends of all trans-
posons described here share the same 70 nt, primer Seq 1 (20)
located within it can sequence the new insert DNA end gen-
erated by all of them. However, Seq 1 loses its uniqueness
after deletions are made from the other end. Primers unique to
each end of the transposons described here are listed in Materi-
als and Methods. Although both orientations of the loxP511
site and the RSV neomycin gene cassette were constructed in
transposons, and analyzed, only those conforming to the
desired uniqueness of sequencing primers are presented in
Figure 5 for clarity.
The 600 base reads obtained from each deletion-end could
BLAST to sequences in the database at the 95–99% homology
level. The sequential order of bands in FIGE of the NotI
digested DNA from deletion clones corresponded with the
order of sequence homology on the chromosome, and
BLASTed to only one strand of DNA.
DISCUSSION
Functionally localizing gene regulatory sequences that operate
over large distances using BAC transgenics requires proced-
ures to systematically delete DNA at either end of inserts.
Both gap-deletions as well as truncations from one end of
the reporter gene-tagged BAC insert have been made either
by a targeted deletion strategy using homologous recombina-
tion, or using loxP transposons (2–5). We believe the loxP
transposon deletion strategy has several advantages over
homology-based targeted deletion methods. Induction of
recombination often triggers intra-insert DNA rearrangements
outside of the regions of homology actually targeted:
mammalian DNA is known to be recombinogenic, and is
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Figure 4. FIGE analysis of NotI digested DNA isolated from deletions made
from the wild-type loxP end. Left panel: DNA isolated from deletion clones
generated with pTnMarkerless2 (28) in BAC RP23-92L23 is shown in lanes
1–13. Lanes 16–30 show DNA from first round deletions generated with
pTn(RSVneo 2)/loxP in clone RP23-444K15. Lane 15 contains DNA from
starting BAC RP23-444K15. Lane 14 shows a 5 kb DNA ladder. The size
of BAC vector DNA fragment is 6.8 and 8.4 kb with pTnMarkerless2 and
pTn(RSVneo 2)/loxP, respectively. The starting BAC produces a 8.8 kb
BAC vector band (lane 15).
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rendered highly recombination deﬁcient (6,7,36).
Occasionally, such intra-insert DNA deletions and/or
rearrangements can become excessively more frequent than
the desirable targeted deletion (P. K. Chatterjee, unpublished
data).
A second, more important, advantage offered by the loxP
transposon-end-deletion procedure is that an entire array of
deletions from a particular end of the BAC insert is obtained in
a single experiment. This library of truncated BAC-GFP dele-
tions can be made without the need to construct new targeting
vectors each time.
The illustrations in Figures 1 and 3 indicate that sequences
ahead of a loxP site are retained in the deleted clone. This
characteristic can be used to bring regulatory sequences that
are far away, or from another gene, to the near vicinity of the
gene of interest during truncations. Exogenous sequences,
inserted at suitable sites in the loxP transposons, can be easily
engineered into a BAC clone to regulate a gene in novel ways.
Studies requiring genes with well deﬁned functional bound-
aries are likely to beneﬁt from the procedures described here.
They allow isolating a gene free of interfering regulatory
elements of an adjacent gene existing in the same BAC clone.
The end-deletion technology can be adapted to handle mul-
tipleBACssimultaneously.However,resultsindicate theyield
of deletions can be skewed unless BACs with similar growth
characteristics are used when pooling.
Recombination of loxP sites with Cre protein has been
widely used in both bacterial and mammalian systems
(19,23,24,26,37–41). The potential for using wild-type and
mutant loxP sites in conjunction is even greater. However,
the results from a number of recent studies suggest the exclus-
ivity between the wild-type and mutant loxP511 sites might
be compromised by the level and persistence of Cre protein
(19,23–26). Results presented here and those from an earlier
study (27) indicate that cross-recombination between wild-
type and mutant loxP sites can be reduced if the Cre protein
is transiently expressed as in a phage P1 infection. The dif-
ferences in speciﬁcity observed between results presented here
and those reported by other investigators earlier might be
related to the different ways by which loxP sites are exposed
to Cre protein in vivo. Although removal of host cell factors
and mutations in transposes relax target site speciﬁcity during
Tn10 and yeast Ty1 insertions (42), there is yet no evidence to
suggest that additional phage encoded and/or induced factors
during a P1 infection alters ﬁdelity of Cre recombinase. Thus
in the absence of evidence for enhanced speciﬁcity conferred
by phage P1 encoded proteins other than Cre, in either bac-
terial or mammalian systems (43,44), these results and previ-
ous work by others (24,26) appear to support the idea that high
levels and/or persistent exposure to Cre protein might in fact
contribute to loxP site promiscuity.
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